Skip to main content
logo
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.025
-0.025 (-1.22%)
At close: Oct 9, 2026, 4:00 PM EDT
1.986
-0.039 (-1.91%)
After-hours: Oct 9, 2026, 5:22 PM EDT

Aytu BioPharma Revenue

In the fiscal year ending June 30, 2026, Aytu BioPharma had annual revenue of $57.57M, down -13.27%. Aytu BioPharma had revenue of $16.11M in the quarter ending June 30, 2026, with 6.42% growth. That makes Aytu BioPharma the 26,880th largest company in the world by revenue and 3,679th in the United States.

Revenue (ttm)
$57.57M
Revenue Growth
-13.27%
P/S Ratio
0.38
Revenue / Employee
$757,500
Employees
76
Market Cap
22.01M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202657.57M-8.81M-13.27%
Jun 30, 202566.38M1.20M1.84%
Jun 30, 202465.18M-42.22M-39.31%
Jun 30, 2023107.40M10.73M11.10%
Jun 30, 202296.67M31.04M47.29%
Jun 30, 202165.63M38.00M137.52%
Jun 30, 202027.63M--
Jun 30, 2019---
Jun 30, 20183.66M-2.78M-43.19%
Jun 30, 20176.44M--
Jun 30, 2016---
Jun 30, 2015261.78K260.78K26,078.20%
Aug 31, 20141.00K-57.93K-98.30%
Jun 30, 201458.93K57.18K3,267.37%
Aug 31, 20131.75K-48.25K-96.50%
Jun 30, 201350.00K48.25K2,757.14%
Aug 31, 20121.75K--
Aug 31, 2011---
Aug 31, 2010---
Aug 31, 20091.75K--
Aug 31, 2008---
Aug 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Rockwell Medical69.39M
Biofrontera46.18M
SCYNEXIS19.22M
Universe Pharmaceuticals INC17.74M
InMed Pharmaceuticals4.94M
China Pharma Holdings3.91M
TherapeuticsMD3.27M
Optimi Health123.70K
Revenue Rankings

AYTU News

More News